Maurizio Musso

Maria Teresa van Lint1
Andrea Bacigalupo1
Alessandra Sperotto1
1Maria Teresa van Lint
1Andrea Bacigalupo
1Alessandra Sperotto
Learn More
BACKGROUND Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for myelofibrosis (MI), though limited by a high rate of transplant-related mortality (TRM). In the present study we evaluate the outcome of MI patients undergoing an allogenic SCT after reduced intensity conditioning (RIC) regimens, and the impact of prognostic(More)
  • 1